You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

11 Results
Guidelines and Advice
Status: Education and Information
ID: 6-7 Version 2
Version: 2
Jun 2013
Guidelines and Advice
Status: Archived
ID: MOAC 1
Nov 2013
Guidelines and Advice
Status: Archived
ID: 12-7
Jun 2013
Guidelines and Advice
Status: Archived
ID: 12-2 Version 2.2003
Version: 2
May 2013
Guidelines and Advice
Status: Archived
ID: 2-25
Dec 2013
Guidelines and Advice
Status: Archived
ID: 5-1
Apr 2013
Guidelines and Advice
Status: Archived
ID: 6-15
Dec 2013
Guidelines and Advice
Status: Archived
ID: 6-2
Version: 2
Aug 2013
Drug
Other Name(s): Lonsurf®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2024
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
teclistamab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    trifluridine / tipiracil - In combination with bevacizumab for treatment of metastatic colorectal cancer, according to clinical criteria
New Drug Funding Program
    Bevacizumab (Biosimilar) - In Combination with Trifluridine and Tipiracil for Previously Treated Metastatic Colorectal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trifluridine / tipiracil,
bevacizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024